Prof. Adi Diab

MD
Professor, Medical Oncology
Co-Director, Melanoma program, Cleveland Clinic Ohaio, USA | Scientific Director of the Cancer Institute, Cleveland Clinic Abu Dhabi, UAE

Prof. Adi Diab is a physician-scientist and academic researcher at the University of Texas MD Anderson Cancer Center. His work focuses on developing novel immunotherapeutic strategies that optimize the interplay between innate and adaptive immunity, including intratumoral approaches with agents such as TLR/CD40 agonists. He also investigates immune-related toxicities, aiming to uncouple tumor immunity from autoimmunity by targeting cytokines such as IL6 and IL1. Prof. Diab has an h-index of 38, with 194 publications, and has previously held affiliations with the University of Texas Health Science Center at Houston and Memorial Sloan Kettering Cancer Center.